Aminolevulinic Acid Hydrochloride Patent Expiration
Aminolevulinic Acid Hydrochloride is Used for treating actinic keratoses on the upper extremities, face, and scalp through photodynamic therapy. It was first introduced by Sun Pharmaceutical Industries Inc
Aminolevulinic Acid Hydrochloride Patents
Given below is the list of patents protecting Aminolevulinic Acid Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Ameluz | US11235169 | Illumination device for photodynamic therapy, method for treating a skin disease and method for operating an illumination device | Oct 15, 2040 | Biofrontera |
Levulan | US10357567 | Methods for photodynamic therapy | Jan 12, 2038 | Sun Pharm Inds Inc |
Levulan | US11077192 | Methods for photodynamic therapy | Jan 12, 2038 | Sun Pharm Inds Inc |
Levulan | US11135293 | Methods for photodynamic therapy | Jan 12, 2038 | Sun Pharm Inds Inc |
Levulan | US11571478 | Methods for photodynamic therapy | Jan 12, 2038 | Sun Pharm Inds Inc |
Levulan | US11690914 | Methods for photodynamic therapy | Jan 12, 2038 | Sun Pharm Inds Inc |
Ameluz | US11540981 | Nanoemulsion formulation with improved stability and cell penetration | Feb 07, 2028 | Biofrontera |
Ameluz | US6559183 | Nano-emulsion of 5-aminolevulinic acid |
Nov 12, 2019
(Expired) | Biofrontera |
Levulan | US7723910 | Method of photodynamically diagnosing or treating a contoured surface |
Jun 17, 2019
(Expired) | Sun Pharm Inds Inc |
Levulan | US6709446 | Illuminator for photodynamic therapy and diagnosis which produces substantially uniform intensity visible light |
May 01, 2018
(Expired) | Sun Pharm Inds Inc |
Levulan | US8216289 | Illuminator for photodynamic therapy |
May 01, 2018
(Expired) | Sun Pharm Inds Inc |
Levulan | US8758418 | Illuminator for photodynamic therapy |
May 01, 2018
(Expired) | Sun Pharm Inds Inc |
Levulan | US5954703 | Method and apparatus for applying 5-aminolevulinic acid |
Oct 31, 2017
(Expired) | Sun Pharm Inds Inc |
Levulan | US5079262 | Method of detection and treatment of malignant and non-malignant lesions utilizing 5-aminolevulinic acid |
Sep 30, 2013
(Expired) | Sun Pharm Inds Inc |
Aminolevulinic Acid Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List